Clinical Trials Directory

Trials / Unknown

UnknownNCT05639140

A Registered Cohort Study on Color Discrimination Deficit Associated With Neurodegenerative Disorders.

A Registered Observational Cohort Study on Color Discrimination Deficit Associated With Neurodegenerative Disorders.

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Fujian Medical University Union Hospital · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Accepted

Summary

Color discrimination deficit is a common manifestation of Alzheimer's disease (AD). However, the pathophysiology of this dysfunction remains poorly understood. The aim of the present study was to evaluate color discrimination using the Farnsworth-Munsell 100 hue test in patients with AD and mild cognitive impairment (MCI), compared with age-matched control subjects. As a secondary aim, we evaluated whether the outcomes of these visual tests were associated with cognitive.

Conditions

Interventions

TypeNameDescription
OTHERData collectionNeuropsychological assessment, FM-1OO, brain MRI, electroencephalogram and biomarker datas will be collected

Timeline

Start date
2018-01-01
Primary completion
2025-07-01
Completion
2025-07-01
First posted
2022-12-06
Last updated
2022-12-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05639140. Inclusion in this directory is not an endorsement.

A Registered Cohort Study on Color Discrimination Deficit Associated With Neurodegenerative Disorders. (NCT05639140) · Clinical Trials Directory